Dana-Farber Cancer Institute
In research, Dana-Farber Cancer Institute stands highest in Medicine (#96 of 10,443 worldwide), Oncology (#8 of 772 worldwide) and Health Sciences (#137 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology, Genetics and Oncology — Hematology is 15.8× its share of world research.
- World rank, 2022–2025
- #400 of 28,054 · #170 all time
- Rank in United States
- #80 of 4,192
- Research works
- 22k ▲ 8% vs 2013–17
- Citations
- 1.6M 76.1 per fractional work
- Top-10% rate
- 23.3% record average 16.5%
- Open access
- 43% world 28%
What is Dana-Farber Cancer Institute known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #96 of 10,443 | 22.0% | 1,982 | #51 | |
| OncologySubfield | #8 of 772 | 23.0% | 540 | #5 | |
| Health SciencesDomain | #137 of 11,982 | 22.0% | 2,070 | #67 | |
| Life SciencesDomain | #97 of 7,800 | 25.9% | 909 | #35 | |
| HematologySubfield | #3 of 117 | 24.1% | 156 | #3 | |
| Molecular BiologySubfield | #64 of 2,175 | 28.0% | 420 | #32 | |
| Pulmonary and Respiratory MedicineSubfield | #34 of 1,144 | 21.9% | 295 | #25 | |
| Biochemistry, Genetics and Molecular BiologyField | #135 of 3,579 | 25.9% | 710 | #70 | |
| GeneticsSubfield | #8 of 98 | 18.0% | 132 | #6 | |
| Immunology and MicrobiologyField | #56 of 682 | 24.9% | 160 | #17 |
Each strip is that field’s whole ranked pool, with the notch where Dana-Farber Cancer Institute sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#51 #96
- Oncology#5 #8
- Health Sciences#67 #137
- Life Sciences#35 #97
- Hematology#3 #3
- Molecular Biology#32 #64
- Pulmonary and Respiratory Medicine#25 #34
- Biochemistry, Genetics and Molecular Biology#70 #135
- Genetics#6 #8
- Immunology and Microbiology#17 #56
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Dana-Farber Cancer Institute specialise in?
Where its research is concentrated relative to its size: Hematology takes 15.8× the share of its output that it takes of world research.
- HematologySubfield · 156.1 works16×
- GeneticsSubfield · 132.1 works15×
- OncologySubfield · 539.8 works15×
- Cancer ResearchSubfield · 161.7 works11×
- ImmunologySubfield · 151.6 works6.7×
- Pulmonary and Respiratory MedicineSubfield · 294.6 works5.8×
- Pathology and Forensic MedicineSubfield · 87.1 works5.1×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.8×. Every wedge is a field page.
- Immunology and Microbiology 4.8×
- Biochemistry, Genetics and Molecular Biology 4.1×
- Medicine 3.1×
- Health Professions 0.9×
- Economics, Econometrics and Finance 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Mathematics 0.4×
- Nursing 0.4×
- Chemistry 0.4×
- Psychology 0.4×
- Neuroscience 0.4×
- Dentistry 0.2×
- Physics and Astronomy 0.2×
- Decision Sciences 0.1×
- Computer Science 0.1×
- Environmental Science 0.1×
- Social Sciences 0.1×
- Veterinary 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Materials Science 0.1×
- Arts and Humanities 0.0×
- Business, Management and Accounting 0.0×
- Earth and Planetary Sciences 0.0×
- Energy 0.0×
Who are the top researchers at Dana-Farber Cancer Institute?
Ranked on the composite score, F. Stephen Hodi, Matthew Meyerson and Bruce E. Johnson lead among researchers whose main affiliation is Dana-Farber Cancer Institute.
- 1 F. Stephen Hodi United States · #137 worldwide 3.4k citations · 149 works
- 2 Matthew Meyerson United States · #149 worldwide 4.2k citations · 138 works
- 3 Bruce E. Johnson United States · #826 worldwide 2k citations · 113 works
- 4 Sabina Signoretti United States · #1,221 worldwide 2k citations · 127 works
- 5 Richard D. Gelber United States · #1,392 worldwide 1.8k citations · 99 works
- 6 Philip W. Kantoff United States · #2,324 worldwide 1.5k citations · 156 works
- 7 Gordon J. Freeman United States · #2,474 worldwide 1.7k citations · 116 works
- 8 Pasi A. Jänne United States · #2,679 worldwide 2.5k citations · 239 works
- 9 Robert J. Mayer United States · #2,815 worldwide 1.2k citations · 96 works
- 10 John Quackenbush United States · #3,434 worldwide 1.6k citations · 79 works
Which keywords describe research at Dana-Farber Cancer Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Prognostic Factors, Tumor Microenvironment, Targeted Therapy, Cancer, Clinical Trials and Cancer Therapy.
- Proteasome Inhibitors
- Hematopoietic Stem Cells
- Metastasis
- Therapeutic Targets
- Cancer Genomics
- Neoadjuvant Therapy
- Chimeric Antigen Receptor
- Precision Medicine
- PD-1 and PD-L1
- Genomic Profiling
- Health-related Quality of Life
- Tumor Regression
- Biomarkers
- Genetic Mutations
- Cancer Immunotherapy
- Radiotherapy
- Cancer Therapy
- Targeted Therapy
- Cancer
- Chemotherapy
- Immunotherapy
- Prognostic Factors
- Tumor Microenvironment
- Clinical Trials
- Lymphoma
- Breast Cancer
- Quality of Life
- Rituximab
- Gene Expression
- Genomic Instability
- PET Imaging
- Immune Checkpoint Blockade
- Leukemia
- CAR T Cells
- Cell-Free DNA
- Somatic Mutations
- Mutational Signatures
- Transcriptional Regulation
- Minimal Residual Disease
- Molecular Characterization
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy337▲ 14×19 topics
- Chemotherapy252▲ 11×24 topics
- Prognostic Factors251▲ 18×14 topics
- Cancer214▲ 4.9×50 topics
- Tumor Microenvironment179▲ 12×8 topics
- Targeted Therapy177▲ 24×5 topics
- Clinical Trials165▲ 7.5×17 topics
- Cancer Therapy142▲ 7.6×19 topics
- Lymphoma136▲ 26×4 topics
- Radiotherapy136▲ 11×13 topics
- Breast Cancer133▲ 17×10 topics
- Cancer Immunotherapy128▲ 26×3 topics
- Quality of Life128▲ 2.7×41 topics
- Genetic Mutations119▲ 8.4×22 topics
- Rituximab117▲ 24×4 topics
- Biomarkers114▲ 5.1×17 topics
- Gene Expression105▲ 5.3×16 topics
- Tumor Regression101▲ 28×2 topics
- Genomic Instability98▲ 27×3 topics
- Health-related Quality of Life92▲ 12×5 topics
- PET Imaging91▲ 16×5 topics
- Genomic Profiling91▲ 27×2 topics
- Immune Checkpoint Blockade90▲ 25×1 topic
- PD-1 and PD-L190▲ 25×1 topic
- Leukemia90▲ 33×2 topics
- Precision Medicine89▲ 5.8×8 topics
- CAR T Cells87▲ 36×1 topic
- Chimeric Antigen Receptor87▲ 36×1 topic
- Cell-Free DNA85▲ 26×2 topics
- Neoadjuvant Therapy84▲ 11×5 topics
- Somatic Mutations83▲ 31×2 topics
- Cancer Genomics82▲ 35×1 topic
- Mutational Signatures82▲ 35×1 topic
- Therapeutic Targets80▲ 16×8 topics
- Transcriptional Regulation79▲ 15×9 topics
- Metastasis79▲ 7.1×12 topics
- Minimal Residual Disease77▲ 34×2 topics
- Hematopoietic Stem Cells75▲ 26×3 topics
- Molecular Characterization74▲ 13×6 topics
- Proteasome Inhibitors72▲ 31×2 topics
Which research topics does Dana-Farber Cancer Institute publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cancer Genomics and Diagnostics and Chronic Lymphocytic Leukemia Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 90 works
- 2 CAR-T cell therapy research Oncology 87 works
- 3 Cancer Genomics and Diagnostics Cancer Research 82 works
- 4 Chronic Lymphocytic Leukemia Research Genetics 68 works
- 5 Cancer survivorship and care Oncology 50 works
- 6 Acute Myeloid Leukemia Research Hematology 50 works
- 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 49 works
- 8 Protein Degradation and Inhibitors Molecular Biology 48 works
- 9 Multiple Myeloma Research and Treatments Hematology 47 works
- 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 46 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Dana-Farber Cancer Institute's research output changed?
Output in 2018–2022 was 8% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Boston
- Boston University
- Massachusetts General Hospital
- Brigham and Women's Hospital
- Northeastern University
- Boston Children's Hospital
- Boston College
- Beth Israel Deaconess Medical Center
- General Electric (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.